| Literature DB >> 36008986 |
Branko Ravić1, Jasmina Debeljak-Martacić1, Biljana Pokimica1, Nevena Vidović1, Slavica Ranković1, Marija Glibetić1, Predrag Stepanović2, Tamara Popović1.
Abstract
The synthesis, degradation, and reconstruction of the cell membrane as a metabolic pathway of phospholipids is a constant and dynamic process. Fatty acids as bioactive lipid components of plasma and erythrocyte phospholipids as structural lipids have biological roles in the integrity of cell membranes. Fatty acids, depending on the chain length, the degree of saturation, and the synthesis pathways, can alleviate inflammation and oxidative stress caused by excessive exercise. Considering that changing food intake or diet can influence fatty acid phospholipid metabolism, our study aimed to determine the potential benefits of fish-based diets in working (police) dogs undergoing intensive training concerning bioactive lipids such as fatty acids, phospholipids of plasma, and erythrocytes. Fatty acid esters' composition of plasma and erythrocyte phospholipids as a bioactive lipids, in addition to markers of oxidative stress and metabolic parameters, were analysed by GC chromatography. The food was well tolerated by all dogs, and the compliance to the diet was high throughout the study. After the treatment with fish-based food, blood glucose, total, and LDL cholesterol levels were significantly reduced, indicating positive biochemical profiles of dogs. Correlations of fatty acid phospholipid compositions between plasma and erythrocytes have shown that both plasma and erythrocytes could represent markers of omega-3 eicosapentaenoic and docosahexaenoic acid intake levels in dogs. Morover, fish-based food supplementation caused a significant reduction in lipid peroxidation markers. The enrichment of dogs' diets with marine fish could improve oxidative status and improve roles and status of bioactive lipids, such as membrane phospholipids and fatty acids, as its components in plasma and erythrocytes in police dogs exposed to intensive exercise.Entities:
Keywords: bioactive lipids; fatty acids; omega-3; oxidative stress; working dogs
Mesh:
Substances:
Year: 2022 PMID: 36008986 PMCID: PMC9405924 DOI: 10.3390/biom12081092
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
The analytical composition of diets.
| Fatty Acid and Macromolecules | Diet 1 (%) | Diet 2 (%) |
|---|---|---|
| PA, 16 0 | 23.14 ± 0.01 | 23.82 ± 0.70 |
| PAO, 16 1 | 3.72 ± 0.26 | 4.76 ± 0.05 ** |
| STE, 18 0 | 9.26 ± 0.26 | 6.63 ± 0.21 ** |
| OA, 18 1 omega-9 | 40.61 ± 0.92 | 36.72 ± 0.83 * |
| VA, 18 1 omega-7 | 3.46 ± 0.33 | 2.98 ± 0.34 |
| LA, 18 2 | 18.07 ± 0.26 | 15.44 ± 1.10 |
| ALA, 18 3 omega-3 | 0.95 ± 0.02 | 2.41 ± 0.70 * |
| DGFLA,20 3 | 0.13 ± 0.02 | 0.10 ± 0.01 |
| AA, 20 4 | 0.36 ± 0.12 | 0.44 ± 0.01 |
| EPA, 20 5 | 0.04 ± 0.02 | 2.68 ± 0.09 *** |
| DTA, 22 4 | 0.13 ± 0.02 | 0.49 ± 00.04 *** |
| DPA, 22 5 omega-3 | 0.08 ± 0.01 | 0.35 ± 0.01 *** |
| DHA, 22 6 | 0.07 ± 0.02 | 3.17 ± 0.24 *** |
| SFA | 32.40 ± 0.27 | 30.45 ± 0.86 |
| MUFA | 47.80 ± 1.33 | 44.46 ± 1.22 |
| PUFA | 19.80 ± 0.49 | 25.08 ± 2.21 * |
| Omega-6 | 18.69 ± 0.16 | 16.73 ± 0.06 |
| Omega-3 | 1.14 ± 0.07 | 8.61 ± 1.04 *** |
| Omega-6/omega-3 | 16.39 ± 1.14 | 1.94 ± 0.05 *** |
| Proteins | 25.74 ± 0.33 | 31.32 ± 2.80 |
| Fat | 16.23 ± 1.42 | 16.50 ± 0.35 |
| Carbohydrates | 46.03 ± 0.53 | 41.24 ± 4.79 |
| Minerals | 7.14 ± 0.74 | 8.31 ± 0.40 |
* p < 0.5, ** p < 0.01, *** p < 0.001, Student T test were used beetween diets.
Changes in biochemical parameters after treatment.
| Biochemical Parameters (mmol/L) | Baseline | After 3 Months |
|---|---|---|
| Glucose | 4.82 (2.8–6.36) | 3.26 (1.74–4.2) *** |
| Triglycerides | 0.64 (0.31–1.03) | 0.54 (0.46–0.94) |
| Cholesterol | 5.86 (3.55–7.01) | 4.47 (3.3–6.85) ** |
| LDL | 0.96 ± 0.62 | 0.54 ± 0.32 * |
| HDL | 4.8 (3.32–6.79) | 4.00 (3.16–6.03) |
Values were presented as mean ± sd and as median with minimal and maximal values *** p < 0.001, ** p < 0.01, * p < 0.05.
Fatty acid profile in plasma phospholipids before and after treatment.
| Fatty Acid (%) | Before | After |
|---|---|---|
| 16 0 | 14.70 ± 1.06 | 17.63 ± 1.19 *** |
| 16 1 | 0.51 ± 1.06 | 0.42 ± 0.07 ns |
| 18 0 | 29.25 ± 1.81 | 29.00 ± 1.78 ns |
| 18 1 omega-9 | 4.99 ± 0.48 | 6.03 ± 0.89 *** |
| 18 1 omega-7 | 1.74 ± 0.22 | 2.25 ± 0.23 *** |
| 18 2 | 24.80 ± 1.98 | 14.48 ± 3.47 *** |
| 18 3 omega-6 | 0.40 ± 0.05 | 0.40 ± 0.04 |
| 18 3 omega-3 | 0.36 ± 0.09 | 0.27 ± 0.13 * |
| 20 3 | 1.75 ± 0.46 | 1.12 ± 0.19 *** |
| 20 4 | 18.45 ± 2.72 | 10.66 ± 1.85 *** |
| 20 5 | 0.25 ± 0.09 | 7.42 ± 2.42 *** |
| 22 4 | 0.79 ± 0.22 | 0.16 ± 0.04 *** |
| 22 5 | 1.94 ± 0.45 | 2.19 ± 0.58 |
| 22 6 | 0.50 ± 0.22 | 7.97 ± 1.64 *** |
| SFA | 43.66 ± 2.29 | 46.64 ± 1.49 *** |
| MUFA | 7.24 ± 1.29 | 8.70 ± 1.15 *** |
| PUFA | 48.84 ± 1.27 | 44.46 ± 1.41 *** |
| Omega-6 | 45.77 ± 1.14 | 26.82 ± 4.00 *** |
| Omega-3 | 3.04 ± 0.64 | 17.85 ± 4.00 *** |
| Omega-6/omega-3 | 15.60 ± 2.92 | 1.69 ± 0.90 *** |
| Omega 3 index | 0.75 ± 0.26 | 15.39 ± 3.63 *** |
| 20 4/20 5 | 82.58 ± 36.51 | 1.79 ± 1.22 *** |
*** p < 0.001, * p < 0.05, ns-non significant.
Fatty acid profiles in erytrocyte phospholipids before and after treatment.
| Fatty Acid (%) | Before | After |
|---|---|---|
| 16 0 | 17.14 ± 1.27 | 19.27 ± 0.79 *** |
| 16 1 | 0.25 ± 0.11 | 0.36 ± 0.09 ns |
| 18 0 | 29.84 ± 1.51 | 27.90 ± 1.03 *** |
| 18 1 omega-9 | 7.12 ± 0.52 | 8.78 ± 0.92 *** |
| 18 1 omega-7 | 1.88 ± 0.13 | 2.32 ± 0.24 *** |
| 18 2 | 13.71 ± 1.03 | 8.55 ± 1.06 *** |
| 18 3 omega-6 | 0.44 ± 0.08 | 0.38 ± 0.05 * |
| 18 3 omega-3 | 0.22 ± 0.05 | 0.14 ± 0.04 *** |
| 20 3 | 2.80 ± 0.33 | 2.08 ± 0.31 *** |
| 20 4 | 23.35 ± 2.34 | 19.51 ± 1.88 *** |
| 20 5 | 0.25 ± 0.06 | 6.04 ± 1.73 *** |
| 22 4 | 1.58 ± 0.26 | 0.60 ± 0.29 *** |
| 22 5 | 0.75 ± 0.18 | 0.91 ± 0.15 ** |
| 22 6 | 0.24 ± 0.15 | 3.24 ± 0.52 *** |
| SFA | 46.98 ± 2.29 | 47.13 ± 0.97 ns |
| MUFA | 9.49 ± 1.16 | 11.46 ± 1.01 *** |
| PUFA | 43.34 ± 1.90 | 41.45 ± 1.41 ** |
| Omega-6 | 41.89 ± 1.86 | 31.12 ± 2.98 *** |
| Omega-3 | 1.45 ± 0.29 | 10.33 ± 2.20 *** |
| Omega-6/omega-3 | 29.81 ± 5.15 | 3.24 ± 1.19 *** |
| Omega-3 index | 0.49 ± 0.15 | 9.28 ± 2.07 *** |
| 20 4/20 5 | 99.78 ± 26.63 | 3.65 ± 1.66 *** |
*** p < 0.001, ** p < 0.01, * p < 0.05, ns-non significant.
Changes in the content of EPA, DHA, and omega-3 PUFA in plasma and erythrocyte phospholipids before and after the treatment (Spearman correlation matrix).
| ∆EPA e | ∆DHA e | ∆omega-3 PUFA e | |
|---|---|---|---|
| ∆EPA p | 0.8382 *** | - | - |
| ∆DHA p | - | 0.5235 * | - |
| ∆omega-3 PUFA p | - | - | 0.6794 ** |
*** p < 0.001, ** p < 0.01, * p < 0.05, e: erythrocytes; p: plasma.
Changes in oxidative stress parameters before and after the treatment.
| Before | After | |
|---|---|---|
| TBARS (µmol/L) | 26.5 ± 9.46 | 22.0 ± 7.15 * |
| 24.5 (8–49) | 20 (12–46) | |
| SOD (U/gHb) | 2268.77 ± 1427.19 | 2577.72 ± 1861.45 |
| 2374.2 (501–6253.5) | 1925.1 (938–8635) | |
| GPx (U/gHb) | 299.68 ± 189.6 | 484.27 ± 233.5 |
| 220.3 (94.4–596.6) | 426.5 (246.4–1042.4) * | |
| Cat (kU/gHb) | 2.08 ± 0.70 | 2.55 ± 1.05 * |
Values are presented as mean ± sd and as median with minimal and maximal values. * p < 0.05.